Eisai mounts targeted TV ad push to raise awareness of Leqembi
Eisai has put direct-to-consumer advertising at the heart of efforts to expand demand for Leqembi. Seeking to grow prescriptions in the U.S., the Japanese drugmaker is targeting TV advertising at recently diagnosed Alzheimer’s disease patients.
Eisai has put direct-to-consumer advertising at the heart of efforts to expand demand for Leqembi. Seeking to grow prescriptions in the U.S., the Japanese drugmaker is targeting TV advertising at recently diagnosed Alzheimer’s disease patients.
